← Back to headlines
AstraZeneca's Wainua Failure Impacts Credibility More Than Valuation
Jefferies warns that the failure of AstraZeneca's drug Wainua is more damaging to the company's credibility than its overall valuation. This setback could affect investor confidence in future drug developments.
9 Jul, 13:15 — 9 Jul, 13:15
Sources
Showing 1 of 1 sources
